Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C33H40N2O9 |
| Molecular Weight | 608.6787 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=C(OC)C=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
InChI
InChIKey=ULBNWNUHGJLQHO-VKMIBBQISA-N
InChI=1S/C33H40N2O9/c1-38-19-7-8-23-22(14-19)20-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)21(18)15-24(35)29(20)34-23/h7-8,11-12,14,18,21,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,21+,24-,27-,28+,31+/m1/s1
| Molecular Formula | C33H40N2O9 |
| Molecular Weight | 608.6787 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Methoserpidine is a synthetic isomer of reserpine, used in the 1960s as an antihypertensive drug. Initially, it was reported to be free from CNS side effects of reserpine (mild suppression of alertness, and mental depression). However, later clinical experience has shown that in a significant proportion of patients administration of the drug lead to episodes of depression.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:46:55 GMT 2025
by
admin
on
Wed Apr 02 08:46:55 GMT 2025
|
| Record UNII |
8F8C1JQH53
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QC02LA04
Created by
admin on Wed Apr 02 08:46:55 GMT 2025 , Edited by admin on Wed Apr 02 08:46:55 GMT 2025
|
||
|
WHO-ATC |
C02LA04
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
||
|
WHO-ATC |
C02AA06
Created by
admin on Wed Apr 02 08:46:55 GMT 2025 , Edited by admin on Wed Apr 02 08:46:55 GMT 2025
|
||
|
WHO-VATC |
QC02AA06
Created by
admin on Wed Apr 02 08:46:55 GMT 2025 , Edited by admin on Wed Apr 02 08:46:55 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8F8C1JQH53
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105867
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | |||
|
C175134
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | |||
|
SUB08855MIG
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | |||
|
100000081435
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | |||
|
m4189
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | Merck Index | ||
|
1750
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | |||
|
235829
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | RxNorm | ||
|
METHOSERPIDINE
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | |||
|
71798
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | |||
|
DB13631
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | |||
|
212-733-5
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | |||
|
1081
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | |||
|
865-04-3
Created by
admin on Wed Apr 02 08:46:55 GMT 2025 , Edited by admin on Wed Apr 02 08:46:55 GMT 2025
|
PRIMARY | |||
|
DTXSID001024699
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY | |||
|
169423
Created by
admin on Wed Apr 02 08:46:56 GMT 2025 , Edited by admin on Wed Apr 02 08:46:56 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |